Horizon Kinetics Asset Management LLC Lantern Pharma Inc. Transaction History
Horizon Kinetics Asset Management LLC
- $7.41 Billion
- Q2 2025
A detailed history of Horizon Kinetics Asset Management LLC transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 27,582 shares of LTRN stock, worth $122,739. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,582
Previous 28,791
4.2%
Holding current value
$122,739
Previous $101,000
13.86%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LTRN
# of Institutions
35Shares Held
2.22MCall Options Held
16.4KPut Options Held
0-
Bios Capital Management, LP Fort Worth, TX1.08MShares$4.79 Million4.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.62 Million0.0% of portfolio
-
Cm Management, LLC200KShares$890,0000.65% of portfolio
-
Geode Capital Management, LLC Boston, MA91.9KShares$408,9140.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny90.6KShares$403,1700.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $48.2M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...